<DOC>
	<DOCNO>NCT01830582</DOCNO>
	<brief_summary>The purpose study see whether three new type MRI technique use magnetic resonance imaging ( MRI ) pelvis look rectal cancer help doctor tell tumor get good response radiation and/or chemotherapy treatment .</brief_summary>
	<brief_title>Advanced MR Imaging Early Biologic Tumor Changes Neoadjuvant Chemoradiation Treatment Rectal Cancer</brief_title>
	<detailed_description>This pilot study dynamic contrast enhance magnetic resonance imaging ( DCE-MRI , aka perfusion MRI ) diffusion-weighted MRI ( DWI-MRI ) , herein refer combination advance MRI ( aMRI ) investigation early tumor response standard multi-dose , fractionate external beam radiotherapy ( EBRT ) pelvis give neoadjuvant set concurrent chemotherapy well induction chemotherapy prior chemoradiotherapy consolidation chemotherapy chemoradiotherapy primary rectal adenocarcinoma . This protocol aim expand upon grow body knowledge concern early change tumor neovascularity cellular density potential biomarker therapy efficacy . It aim address trend towards refine treatment stratification low risk tumor avoid morbidity potentially unnecessary radiation , chemotherapy even radical surgery , assess early change occur microvasculature perfusion diffusion water treatment see predictive long-term efficacy therapy .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Patients primary locally advanced rectal adenocarcinoma ( 018cm anal verge ) confirm MSKCC pathologist eligible undergo chemoradiation surgical resection MSKCC . Written inform consent Age equal great 21 year Willing able undergo study procedures Patients must plan surgical resection rectum Patients young 21 year Pregnant nursing woman Contraindications MRI ( claustrophobia , pacemaker , non MRcompatible artificial heart valve , cochlear implant , surgical clip brain , metal fragment eye ) Estimated GFR ( use Cockcroft formula Appendix 2 ) less 30 ml/min/1.73m2 ( FDA advise caution use gadoliniumbased contrast agent patient severe renal impairment ) . History allergic reaction MR contrast medium Inability give inform consent person</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>MRI</keyword>
	<keyword>rectum</keyword>
	<keyword>13-019</keyword>
</DOC>